Jamie Laursen

Jamie Laursen has a diverse work experience that spans over several companies. In 2005, Jamie began their career as a Pharmaceutical Sales Specialist at AstraZeneca, where they worked until 2008. From 2009 to 2010, Jamie worked as an Analyst in Investment Sourcing and Diligence at Avantage Ventures. In 2011, Jamie joined AB Bernstein as the VP of Institutional Equity Research Sales for Asian Equities, and later became the Director of Institutional Equity Research Sales for US Equities in 2015. From 2021 to 2022, Jamie worked in Business Development/Capital Raising for AB Arya, and currently holds the position of Head of North America Business Development for AB Public Alternatives.

Jamie Laursen has a Bachelor of Science degree in BioChemistry from the University of North Carolina at Chapel Hill. Additionally, they have completed an MBA in Finance from the NYU Stern School of Business. Their education history also includes attending the HKUST Business School, and they have previously studied at the Charlotte Country Day School. However, the specific degree and field of study for these two institutions are not provided.